Remote monitoring for patients with chronic heart failure shows significant benefits

Researchers from Canada and Australia have found that the use of remote monitoring for patients with chronic heart failure has the potential to significantly improve clinical outcomes (mortality, morbidity and quality indicators).

The use of remote monitoring (telephone support or telemonitoring) to electronically transfer a patients' physiological data such as blood pressure, weight and ECG and oxygen details, to their healthcare provider has increased in prevalence over the past years. According to research recently published in The British Medical Journal, remote monitoring for patients with chronic heart failure helped reduce heart failure admissions to hospitals and lowered all cause mortality by nearly twenty per cent.

"What we found is that the use of remote monitoring programs can improve outcomes in patients with heart failure and such an approach could help deal with the increasing number of patients with chronic heart failure that cannot be accommodated in existing specialty clinics due to access issues related to geography, lack of resources or infirmity," said Dr. Finlay McAlister, University of Alberta researcher.

Because remote monitoring (either through close telephone follow-up with specially trained nurses or telemonitoring involving the daily transmission of a patient's vital signs, weight and symptoms to health care providers) permits closer follow-up of patients with heart failure, this allows for the potential for earlier detection and management of changes in a patient's health.

"It must be noted that although we have found substantial benefits with remote monitoring for patients with chronic heart failure, telephone monitoring is not a treatment, but rather a different way of providing effective care," said Dr. McAlister. "Therefore, programs that include remote monitoring should not be seen as a replacement for specialist care or multidisciplinary care clinics, but instead should be viewed as a potential adjunct."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients